Drug Interaction Potential of 2-((3,4-Dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the Novel Nonstatin-Type Cholesterol-Lowering Agent-Reference-Cited by-同舟云学术

Drug Interaction Potential of 2-((3,4-Dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the Novel Nonstatin-Type Cholesterol-Lowering Agent

Published:2008-10-29 Issue:2 Volume:37 Page:375-385
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Monostory Katalin,Pascussi Jean-Marc,Szabó Pál,Temesvári Manna,Köhalmy Krisztina,Acimovic Jure,Kocjan Darko,Kuzman Drago,Wilzewski Britta,Bernhardt Rita,Kóbori László,Rozman Damjana

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference41 articles.

1. Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer

2. The safety of statins in clinical practice

3. Bayliss KM and Skett P (1996) Isolation and culture of human hepatocytes, in Human Cell Culture Protocols (Jones GE ed) pp 369–390, Humana Press, Totowa, NJ.

4. Ezetimibe: cholesterol lowering and beyond

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of membrane composition on the interaction between human CYP51 and its flavonoid inhibitor - luteolin 7,3′-disulfate;Biochimica et Biophysica Acta (BBA) - Biomembranes;2024-03

2. Human Lanosterol 14-Alpha Demethylase (CYP51A1) Is a Putative Target for Natural Flavonoid Luteolin 7,3′-Disulfate;Molecules;2021-04-13

3. A functional long‐term 2D serum‐free human hepatic in vitro system for drug evaluation;Biotechnology Progress;2020-10-03

4. Genetic Variability in Cholesterol Metabolism;Mammalian Sterols;2020

5. Rosuvastatin and Atorvastatin Are Ligands of the Human Constitutive Androstane Receptor/Retinoid X Receptor α Complex;Drug Metabolism and Disposition;2017-05-23